炎症与成纤维细胞生长因子23水平升高是慢性肾脏病死亡的独立危险因素
在3875例慢性肾脏病2至4期患者中开展前瞻性研究,中位随访6.9年,550例在进展至终末期肾病前死亡(20.5/1000人年)。白细胞介素-6、高敏C反应蛋白和成纤维细胞生长因子23(FGF23)水平升高均独立与死亡风险增加相关,炎症与FGF23同时处于最高四分位者死亡风险最高。
要点
- 白细胞介素-6、C反应蛋白和FGF23水平升高均独立与慢性肾脏病患者死亡风险增加相关。
- 白细胞介素-6与FGF23均处于最高四分位者,多变量校正后死亡风险比为4.38(95%CI 2.65-7.23)。
- C反应蛋白与FGF23均处于最高四分位者,多变量校正后死亡风险比为5.54(95%CI 3.04-10.09)。
核心结论
- 白细胞介素-6、C反应蛋白和FGF23水平升高是慢性肾脏病患者死亡的独立危险因素。
研究设计与样本
- 前瞻性研究,纳入慢性肾脏病2至4期参与者3875例,来自慢性肾功能不全队列(CRIC)研究。
- 检测基线血浆白细胞介素-6、高敏C反应蛋白和FGF23水平,分析其与全因死亡(以终末期肾病发生为删失)的关联。
主要发现
- 中位随访6.9年,550例参与者在终末期肾病前死亡(20.5/1000人年)。
- 单独多变量校正分析中,白细胞介素-6每增加一个标准差(自然对数转换后)的死亡风险比为1.35(95%CI 1.25-1.46)。
- C反应蛋白每增加一个标准差的死亡风险比为1.28(95%CI 1.16-1.40)。
- FGF23每增加一个标准差的死亡风险比为1.45(95%CI 1.32-1.60)。
- 进一步校正FGF23后,白细胞介素-6和C反应蛋白与死亡风险的关联仅轻微减弱。
关键数值与推荐
- 与炎症和FGF23均处于最低四分位者相比,白细胞介素-6和FGF23均处于最高四分位者的多变量校正死亡风险比为4.38(95%CI 2.65-7.23)。
- 与炎症和FGF23均处于最低四分位者相比,C反应蛋白和FGF23均处于最高四分位者的多变量校正死亡风险比为5.54(95%CI 3.04-10.09)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inflammation is a consequence of chronic kidney disease (CKD) and is associated with adverse outcomes in many clinical settings. Inflammation stimulates production of fibroblast growth factor 23 (FGF23), high levels of which are independently associated with mortality in CKD. Few large-scale prospective studies have examined inflammation and mortality in patients with CKD, and none tested the interrelationships among inflammation, FGF23, and risk of death. Therefore, we conducted a prospective investigation of 3875 participants in the Chronic Renal Insufficiency Cohort (CRIC) study with CKD stages 2 to 4 to test the associations of baseline plasma interleukin-6, high-sensitivity C-reactive protein, and FGF23 levels with all-cause mortality, censoring at the onset of end-stage renal disease. During a median follow-up of 6.9 years, 550 participants died (20.5/1000 person-years) prior to end-stage renal disease. In separate multivariable-adjusted analyses, higher levels of interleukin-6 (hazard ratio per one standard deviation increase of natural log-transformed levels) 1.35 (95% confidence interval, 1.25-1.46), C-reactive protein 1.28 (1.16-1.40), and FGF23 1.45 (1.32-1.60) were each independently associated with increased risk of death. With further adjustment for FGF23, the risks of death associated with interleukin-6 and C-reactive protein were minimally attenuated. Compared to participants in the lowest quartiles of inflammation and FGF23, the multivariable-adjusted hazard ratio of death among those in the highest quartiles of both biomarkers was 4.38 (2.65-7.23) for interleukin-6 and FGF23, and 5.54 (3.04-10.09) for C-reactive protein and FGF23. Thus, elevated levels of interleukin-6, C-reactive protein, and FGF23 are independent risk factors for mortality in CKD.
引用
- Munoz Mendoza J, Isakova T, Cai X, et al. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney Int. 2016. PMID: 28017325. doi:10.1016/j.kint.2016.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。